Canaccord Genuity Ltd. appointed Julian Feneley head of healthcare investment banking in Europe.
Feneley will be based in London and report to Adrian Haxby, Canaccord’s head of European investment banking, Canaccord Genuity said in an e-mailed statement today. Canaccord Genuity is the investment banking unit of Canaccord Financial Inc., based in Vancouver.
His previous positions include serving as head of Britesmile Inc., a seller of a teeth-whitening system. He also worked as senior member of the JPMorgan Chase & Co. (JPM:US) healthcare investment-banking team in Europe, advising on transactions such as the creation of Novartis AG and AstraZeneca Plc.
Feneley “will play a key role in further strengthening our advisory capabilities in this important sector,” Alexis de Rosnay, chief executive officer of Canaccord Genuity’s U.K. and European operations, said in today’s statement.
Feneley has been a doctor at Guy’s Hospital in London, graduated from London University, and worked in both Europe and the U.S., Canaccord Genuity said.
To contact the reporter on this story: Albertina Torsoli in Paris at firstname.lastname@example.org
To contact the editor responsible for this story: Phil Serafino at email@example.com